GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Other Current Receivables

Rising Biosciences (Rising Biosciences) Other Current Receivables : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Other Current Receivables?

Rising Biosciences's Other Current Receivables for the quarter that ended in . 20 was $0.00 Mil.


Rising Biosciences Other Current Receivables Historical Data

The historical data trend for Rising Biosciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Other Current Receivables Chart

Rising Biosciences Annual Data
Trend
Other Current Receivables

Rising Biosciences Quarterly Data
Other Current Receivables

Rising Biosciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Rising Biosciences Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

Rising Biosciences Set To Acquire All Assets from PAO Group

By Marketwired Marketwired 11-07-2018